Gotham Therapeutics
Founded
2017
2017
Geography
United States of America based
United States of America based
Funding
$54 M
$54 M
Gotham Therapeutics has assembled an exceptional team and network to establish a novel drug class targeting RNA-modifying proteins. By changing the activity of proteins that modify messenger RNA, we aim to develop new treatment options for patients suffering from cancers, auto-immune and neurodegenerative diseases. We are applying a 360-degree approach to small molecule drug design to build a pipeline based on the promise of this rapidly emerging biopharmaceutical field.
Technologies
Pharmaceutical and Drug Discovery RNA-focused StartupsR&D Platform
Pipelines
No pipelines published yet
Products
Services
No services posted yet